RATIONALE: Repeated, short-term exposures to ozone (O3) lead to attenuation of the acute lung function and airway inflammatory responses seen after a single exposure in healthy subjects, but it is unclear whether these acute responses also attenuate in subjects with asthma. OBJECTIVE: To address this question by exposing 14 subjects with asthma to 0.2 ppm O3 for either 4 hours on a single day or 4 hours on 4 consecutive days (multiday [MD]). At least 3 weeks later, subjects underwent the alternate exposure. METHODS: Spirometry was performed immediately pre- and postexposure and bronchoalveolar lavage (BAL) was obtained 18 hours after each exposure. MAIN RESULTS: The decrease in FEV1 was greatest across Day 2 of the MD (MD2) exposure and then gradually declined on successive days of the MD exposure (mean +/- SD decrease in FEV1 of 25.4 +/- 18.0% across MD2 compared with 4.2 +/- 6.5% across MD4). Respiratory symptoms followed a similar pattern to that of FEV1. Although the concentration of neutrophils in BAL after the MD4 exposure was not significantly different from that after the single-day exposure (1.7 +/- 1.3 x 10(4) cells/ml vs. 1.2 +/- 0.8 x 10(4) cells/ml, p = 0.20), the concentration of alveolar macrophages did significantly increase in BAL after the MD exposure (19.9 +/- 9.7 x 10(4) cells/ml after MD4 vs. 12.1 +/- 6.4 x 10(4) cells/ml after the single day). CONCLUSIONS: Alveolar macrophages are recruited to the airways of subjects with asthma with repeated short-term exposures to O3, suggesting a possible role for these cells in the chronic response to oxidant-induced injury.
RATIONALE: Repeated, short-term exposures to ozone (O3) lead to attenuation of the acute lung function and airway inflammatory responses seen after a single exposure in healthy subjects, but it is unclear whether these acute responses also attenuate in subjects with asthma. OBJECTIVE: To address this question by exposing 14 subjects with asthma to 0.2 ppm O3 for either 4 hours on a single day or 4 hours on 4 consecutive days (multiday [MD]). At least 3 weeks later, subjects underwent the alternate exposure. METHODS: Spirometry was performed immediately pre- and postexposure and bronchoalveolar lavage (BAL) was obtained 18 hours after each exposure. MAIN RESULTS: The decrease in FEV1 was greatest across Day 2 of the MD (MD2) exposure and then gradually declined on successive days of the MD exposure (mean +/- SD decrease in FEV1 of 25.4 +/- 18.0% across MD2 compared with 4.2 +/- 6.5% across MD4). Respiratory symptoms followed a similar pattern to that of FEV1. Although the concentration of neutrophils in BAL after the MD4 exposure was not significantly different from that after the single-day exposure (1.7 +/- 1.3 x 10(4) cells/ml vs. 1.2 +/- 0.8 x 10(4) cells/ml, p = 0.20), the concentration of alveolar macrophages did significantly increase in BAL after the MD exposure (19.9 +/- 9.7 x 10(4) cells/ml after MD4 vs. 12.1 +/- 6.4 x 10(4) cells/ml after the single day). CONCLUSIONS: Alveolar macrophages are recruited to the airways of subjects with asthma with repeated short-term exposures to O3, suggesting a possible role for these cells in the chronic response to oxidant-induced injury.
Authors: Isabelle Romieu; Juan José Sienra-Monge; Matiana Ramírez-Aguilar; Martha María Téllez-Rojo; Hortensia Moreno-Macías; Norma Isabel Reyes-Ruiz; Blanca Estela del Río-Navarro; María Xóchitl Ruiz-Navarro; Gary Hatch; Ralph Slade; Mauricio Hernández-Avila Journal: Am J Respir Crit Care Med Date: 2002-09-01 Impact factor: 21.405
Authors: Lisa L Chen; Ira B Tager; David B Peden; Dorothy L Christian; Ronald E Ferrando; Barbara S Welch; John R Balmes Journal: Chest Date: 2004-06 Impact factor: 9.410
Authors: J Bosson; N Stenfors; A Bucht; R Helleday; J Pourazar; S T Holgate; F J Kelly; T Sandström; S Wilson; A J Frew; A Blomberg Journal: Clin Exp Allergy Date: 2003-06 Impact factor: 5.018
Authors: Gautam Damera; William F Jester; Meiqi Jiang; Hengjiang Zhao; Homer W Fogle; Michael Mittelman; Angela Haczku; Edwin Murphy; Indu Parikh; Reynold A Panettieri Journal: Exp Lung Res Date: 2010-03 Impact factor: 2.459
Authors: Neil E Alexis; John C Lay; Milan Hazucha; Bradford Harris; Michelle L Hernandez; Philip A Bromberg; Howard Kehrl; David Diaz-Sanchez; Chong Kim; Robert B Devlin; David B Peden Journal: Inhal Toxicol Date: 2010-06 Impact factor: 2.724
Authors: Gautam Damera; Hengjiang Zhao; Miao Wang; Michael Smith; Christopher Kirby; William F Jester; John A Lawson; Reynold A Panettieri Journal: Am J Physiol Lung Cell Mol Physiol Date: 2009-02-06 Impact factor: 5.464
Authors: Philip R Cooper; A Clementina Mesaros; Jie Zhang; Peter Christmas; Christopher M Stark; Karim Douaidy; Michael A Mittelman; Roy J Soberman; Ian A Blair; Reynold A Panettieri Journal: PLoS One Date: 2010-04-20 Impact factor: 3.240
Authors: Jill A Poole; Neil E Alexis; Conrad Parks; Amy K MacInnes; Martha J Gentry-Nielsen; Paul D Fey; Lennart Larsson; Diane Allen-Gipson; Susanna G Von Essen; Debra J Romberger Journal: J Allergy Clin Immunol Date: 2008-06-27 Impact factor: 10.793